Life Sciences Acceleration Alliance
@LSAAllianceLSAA is a coalition of investment, scientific and corporate leaders dedicated to strengthening life sciences research and development in Europe.
Similar User
@FlotBio
@AdBiopartners
@SmartImmune_off
@MutHDF
@PointBiotech
@MrBergerVC
In 2020, US #biotechnology companies invested about 11 times as much money in their R&D as European companies. To drive more investment, encourage growth and stay competitive on the global market, the EU needs greater incentives. Visit bit.ly/3jy8vVQ to read our report
In case you missed it, take a look at Christian Pierret's Les Echos piece on the European Commission's upcoming pharmaceutical proposal.
Check out Christian Pierret's thoughts on European funding for #innovation, the duration of patent protection, and other hot life sciences topics in his Les Echos opinion out last week. #lifesciences #patentprotection bit.ly/3LpvrSK
Check out Christian Pierret's thoughts on European funding for #innovation, the duration of patent protection, and other hot life sciences topics in his Les Echos opinion out last week. #lifesciences #patentprotection bit.ly/3LpvrSK
In the wake of the drug pricing policies set by the Inflation Reduction Act, European policy makers may have an opportunity to build an inviting environment for the early-stage life science ecosystem. Watch our full webinar here: bit.ly/3DuHutr #InflationReductionAct
What should the European Commission consider as it undertakes its review of #pharmaceutical legislation? Incubate Coalition Executive Director John Stanford thinks two of the most important considerations are not only economic costs, but patient costs. bit.ly/3gn5Egt
At #HTID4 Hubert Gambs, Deputy Director-General DG Grow, was asked about the big initiatives coming up at an EU-level - including the revision of the pharmaceutical legislation. Watch his take on the subject here. #investors #IPrights #VCs
Investment in medicines impacted by the U.S' Inflation Reduction Act will plummet. In the growing EU life science market, imagine what similar price setting measures could mean for the future development of life saving drugs. Watch our full webinar here bit.ly/3EQvraZ
#TBT to #HTID4 & the amazing time we had with the new edition’s participants/panelists (VCs, Investors...) from all over the world. It's always great to connect/meet with those who are making a difference. Special shoutout to Cedric Moreau from @SofinnovaVC & #HTID2022 organizers
#HTID4: here we go for a second day of conferences and conversations with key actors of the #LifeScience investment community! #LSAA
Listen to @westermann_r , Chairman of @LSAAlliance , gold sponsor of HTID#4. After the launch of LSAA during HTID#3, LSAA is back, just discover why! Meet LSAA during HTID#4 on October 13&14 2022! More information: htfc-eu.com/htid/
"The pandemic and the past two years should be a wake up call for all of us. We need investors and #VCs to stand together to limit #TRIPSwaiver impact on the longterm." Yann Le Flohic, Deputy Chairman of #LSAA at #HTID4
"The EU commission is planning to review its current regulations, after more than 20 years. This could either go wrong or go right. But let's say that this is a great opportunity for Europe to rethink its framework & rebuild its independence, attractiveness & leadership." - LSAA
"Although the Ukrainian & Russian conflict is impacting investment and resources, VCs are still continuing to support biotech. Pharma companies are looking for innovation & we are seeing an increase in M&A activity with American investors coming to Europe" Elena Coluccelli #HTID4
LSAA was part of the panel on “Covid wake up call on health innovation investments: opportunities and turbulence” along other key actors in the industry. Thank you to Cédric Moreau for moderating the conversation. #LSAA #HTID4
Heard at #HTID4: "Translating Scientific Discoveries into Health Technologies: #IPprotection is critical in this complex journey." - Michel Goldman, President I3h Institute at the Free University of Brussels.
LSAA is very pleased to attend the #HTID again this year. Starting off the day with this powerful quote from Pierre Courteille: “Europe needs dynamic, resilient ecosystems, provider of innovative solutions and growth financing”. Stay tuned for more live updates! #LSAA #HTID4
We are very disappointed that #EU changed its position on Waiving IP for COVID technologies. States should be concerned. What should investors expect in the future if IP is not respected? Read what this means for future #innovations in the medical sector. bit.ly/3ai0Eqi
#DBT2022 #Innovationen im Bereich #Biotechnologie in Deutschland: wir brauchen gezielte Agenda, die #Investitionsanreize schafft. Rahmenbedingungen für private #Investoren müssen verbessert werden. #VentureCapital #lifescience @BIODeutschland
#DBT2022 It‘s a long way for #biotech #Startups to actually make it from a great idea to the last phase, the #Commercialization. Without an ecosystem supporting partnerships and capitalization #innovation isn‘t possible. @glpg_DE #VentureCapital #lifesciences
#Biotechnology is the focus of #DBT2022 in Hamburg. It‘s all about #Innovation, #Technology and #Enablement
Check out Christian Pierret's thoughts on European funding for #innovation, the duration of patent protection, and other hot life sciences topics in his Les Echos opinion out last week. #lifesciences #patentprotection bit.ly/3LpvrSK
United States Trends
- 1. #AskFFT N/A
- 2. #RollWithUs 1.886 posts
- 3. $CUTO 13,3 B posts
- 4. Go Birds 3.281 posts
- 5. #LINК 524 B posts
- 6. #FFNow N/A
- 7. #sundayvibes 7.373 posts
- 8. Good Sunday 78,6 B posts
- 9. Garnacho 16,5 B posts
- 10. Full PPR 1.011 posts
- 11. Thielen 2.083 posts
- 12. Waddle 2.622 posts
- 13. Pacheco 6.943 posts
- 14. Sunday Funday 4.868 posts
- 15. DeFi 186 B posts
- 16. Xmas Drop 1.660 posts
- 17. $BOOST 11,5 B posts
- 18. Breece 1.650 posts
- 19. Mooney 3.220 posts
- 20. Deion 19,8 B posts
Something went wrong.
Something went wrong.